vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.

CVRx, Inc. is the larger business by last-quarter revenue ($16.0M vs $11.1M, roughly 1.4× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -74.5%, a 85.4% gap on every dollar of revenue. On growth, CVRx, Inc. posted the faster year-over-year revenue change (4.4% vs -5.6%). Over the past eight quarters, CVRx, Inc.'s revenue compounded faster (22.0% CAGR vs -3.8%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.

CVRX vs MDV — Head-to-Head

Bigger by revenue
CVRX
CVRX
1.4× larger
CVRX
$16.0M
$11.1M
MDV
Growing faster (revenue YoY)
CVRX
CVRX
+10.0% gap
CVRX
4.4%
-5.6%
MDV
Higher net margin
MDV
MDV
85.4% more per $
MDV
11.0%
-74.5%
CVRX
Faster 2-yr revenue CAGR
CVRX
CVRX
Annualised
CVRX
22.0%
-3.8%
MDV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVRX
CVRX
MDV
MDV
Revenue
$16.0M
$11.1M
Net Profit
$-11.9M
$1.2M
Gross Margin
86.3%
Operating Margin
-69.8%
45.8%
Net Margin
-74.5%
11.0%
Revenue YoY
4.4%
-5.6%
Net Profit YoY
-12.0%
-22.0%
EPS (diluted)
$-0.45
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
MDV
MDV
Q4 25
$16.0M
$11.1M
Q3 25
$14.7M
$11.7M
Q2 25
$13.6M
$11.8M
Q1 25
$12.3M
$11.8M
Q4 24
$15.3M
$11.7M
Q3 24
$13.4M
$11.7M
Q2 24
$11.8M
$11.4M
Q1 24
$10.8M
$12.0M
Net Profit
CVRX
CVRX
MDV
MDV
Q4 25
$-11.9M
$1.2M
Q3 25
$-12.9M
$1.0M
Q2 25
$-14.7M
$-2.0M
Q1 25
$-13.8M
$829.0K
Q4 24
$-10.7M
$1.6M
Q3 24
$-13.1M
$-587.0K
Q2 24
$-14.0M
$1.3M
Q1 24
$-22.2M
$3.7M
Gross Margin
CVRX
CVRX
MDV
MDV
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
Q1 24
85.0%
Operating Margin
CVRX
CVRX
MDV
MDV
Q4 25
-69.8%
45.8%
Q3 25
-83.5%
41.4%
Q2 25
-105.8%
9.8%
Q1 25
-108.8%
40.2%
Q4 24
-67.0%
45.4%
Q3 24
-97.3%
42.0%
Q2 24
-118.3%
44.6%
Q1 24
-206.4%
55.6%
Net Margin
CVRX
CVRX
MDV
MDV
Q4 25
-74.5%
11.0%
Q3 25
-87.6%
9.0%
Q2 25
-108.4%
-17.1%
Q1 25
-111.5%
7.0%
Q4 24
-69.4%
13.3%
Q3 24
-98.0%
-5.0%
Q2 24
-118.8%
11.6%
Q1 24
-206.0%
31.1%
EPS (diluted)
CVRX
CVRX
MDV
MDV
Q4 25
$-0.45
$0.02
Q3 25
$-0.49
$0.00
Q2 25
$-0.57
$-0.32
Q1 25
$-0.53
$-0.01
Q4 24
$-0.39
$0.07
Q3 24
$-0.57
$-0.18
Q2 24
$-0.65
$0.03
Q1 24
$-1.04
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
MDV
MDV
Cash + ST InvestmentsLiquidity on hand
$75.7M
$14.4M
Total DebtLower is stronger
$261.5M
Stockholders' EquityBook value
$39.3M
$162.7M
Total Assets
$104.8M
$476.5M
Debt / EquityLower = less leverage
1.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
MDV
MDV
Q4 25
$75.7M
$14.4M
Q3 25
$85.1M
$8.3M
Q2 25
$95.0M
$5.8M
Q1 25
$102.7M
$6.2M
Q4 24
$105.9M
$11.5M
Q3 24
$100.2M
$6.8M
Q2 24
$70.4M
$18.9M
Q1 24
$80.1M
$18.4M
Total Debt
CVRX
CVRX
MDV
MDV
Q4 25
$261.5M
Q3 25
$279.7M
Q2 25
$279.7M
Q1 25
$279.7M
Q4 24
$279.8M
Q3 24
$279.7M
Q2 24
$279.7M
Q1 24
$279.6M
Stockholders' Equity
CVRX
CVRX
MDV
MDV
Q4 25
$39.3M
$162.7M
Q3 25
$48.1M
$164.8M
Q2 25
$57.9M
$165.6M
Q1 25
$71.1M
$171.1M
Q4 24
$71.1M
$190.1M
Q3 24
$65.2M
$186.3M
Q2 24
$55.2M
$187.0M
Q1 24
$66.3M
$188.0M
Total Assets
CVRX
CVRX
MDV
MDV
Q4 25
$104.8M
$476.5M
Q3 25
$111.3M
$499.6M
Q2 25
$119.6M
$498.9M
Q1 25
$129.6M
$506.8M
Q4 24
$133.4M
$507.8M
Q3 24
$127.7M
$507.4M
Q2 24
$96.0M
$519.5M
Q1 24
$106.2M
$522.5M
Debt / Equity
CVRX
CVRX
MDV
MDV
Q4 25
1.61×
Q3 25
1.70×
Q2 25
1.69×
Q1 25
1.63×
Q4 24
1.47×
Q3 24
1.50×
Q2 24
1.50×
Q1 24
1.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
MDV
MDV
Operating Cash FlowLast quarter
$-9.8M
$15.0M
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-61.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
12.34×
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
MDV
MDV
Q4 25
$-9.8M
$15.0M
Q3 25
$-9.7M
$4.1M
Q2 25
$-7.9M
$3.9M
Q1 25
$-12.8M
$3.0M
Q4 24
$-8.0M
$18.2M
Q3 24
$-10.4M
$5.1M
Q2 24
$-9.8M
$4.7M
Q1 24
$-10.9M
$3.0M
Free Cash Flow
CVRX
CVRX
MDV
MDV
Q4 25
$-9.8M
Q3 25
$-10.0M
Q2 25
$-8.0M
Q1 25
$-12.9M
Q4 24
$-8.1M
Q3 24
$-10.4M
Q2 24
$-10.2M
Q1 24
$-11.8M
FCF Margin
CVRX
CVRX
MDV
MDV
Q4 25
-61.3%
Q3 25
-68.1%
Q2 25
-59.2%
Q1 25
-104.3%
Q4 24
-52.5%
Q3 24
-78.1%
Q2 24
-86.3%
Q1 24
-109.7%
Capex Intensity
CVRX
CVRX
MDV
MDV
Q4 25
0.4%
Q3 25
2.0%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
3.0%
Q1 24
8.5%
Cash Conversion
CVRX
CVRX
MDV
MDV
Q4 25
12.34×
Q3 25
3.95×
Q2 25
Q1 25
3.68×
Q4 24
11.72×
Q3 24
Q2 24
3.55×
Q1 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

MDV
MDV

Segment breakdown not available.

Related Comparisons